APLS vs LMAT

APLS exhibits weak financial health per the Piotroski F-Score of 4/9, indicating a fragile foundation despite some positive gross margins and cash reserves. The company is unprofitable with negative operating margins and declining revenue, while insider selling activity and a bearish technical trend signal pessimism. Although the Graham Number ($3.44) and intrinsic value ($1.26) suggest deep undervaluation, the current price of $18.94 reflects high growth expectations that are not supported by fundamentals. The absence of an Altman Z-Score raises concern about default risk, especially given a debt/equity ratio of 1.28 and negative earnings. Analysts recommend 'buy' with a target of $33.60, but this optimism appears disconnected from deteriorating operational and financial trends.

LMAT exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and exceptional liquidity, but it is currently facing a severe valuation disconnect. While the company shows strong growth (41.4% earnings growth) and high gross margins, the current price of $114.62 significantly exceeds both the Graham Number ($31.3) and the growth-based Intrinsic Value ($74.34). This premium is further complicated by heavy insider selling, including a large divestment by the CEO, and a bearish technical trend despite the price being near 52-week highs.